FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

9 letters match. Newest first.

  1. Shenzhen Moyeah Intelligent Life Technology Co.

    Shenzhen Moyeah sold ozone and UV CPAP cleaner and sanitizer devices in the U.S. without FDA clearance or approval, FDA says.

    High risk
  2. Natures Pillows, Inc. and Top Dog Direct, LLC

    FDA warns Natures Pillows and Top Dog Direct that Clean Zone CPAP Sanitizer is an unapproved, misbranded device.

    High risk
  3. Spectrum Medical Ltd

    Spectrum Medical marketed Quantum perfusion devices beyond cleared uses and had corrective-action failures.

    High risk
  4. Neurotris, Inc. dba A1 Engineering

    FDA warns Neurotris over unapproved, misbranded facial/body stimulator devices and quality system violations.

    High risk
  5. King Systems Corp. dba Ambu, Inc.

    FDA warns Ambu's King Systems over unapproved King LTS-D airway device and pediatric website claims.

    High risk
  6. Outset Medical, Inc.

    FDA warns Outset Medical over unapproved TabloCart and promotion of Tablo dialysis system for unapproved CRRT use.

    High risk
  7. CreativeStar Solutions

    CreativeStar Solutions offered Artemis thermal scanners for sale online with claims they prevent COVID-19, unapproved by FDA.

    High risk
  8. Thermavis

    FDA warned UK firm Thermavis that it sells an uncleared thermal screening camera with COVID-19 claims, calling the product adulterated and misbranded.

    High risk
  9. Dubak Electrical Group

    FDA warned Dubak Electrical Group that its DuThermX temperature-screening device was illegally marketed for COVID-19 use.

    High risk